Liabilities / Assets
29th percentile
Higher debt load relative to assets than 29% of similar nonprofits.
990 • Fiscal year 2011 • EIN 20-4795033
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
29th percentile
Higher debt load relative to assets than 29% of similar nonprofits.
Liabilities / Revenue
28th percentile
Higher debt load relative to revenue than 28% of similar nonprofits.
Net Margin
26th percentile
Higher net margin than 26% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
24th percentile
Faster asset growth than 24% of similar nonprofits.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
Down$911,076
Down $67,191 (-6.9%) from 2010
Net Assets
Down$907,092
Down $59,513 (-6.2%) from 2010
Liabilities
Down$3,984
Down $7,678 (-66%) from 2010
Revenue
$937,629
No earlier filing loaded for comparison.
Expenses
Up$997,143
Up $385,132 (+63%) from 2010
Net Income
-$59,514
No earlier filing loaded for comparison.
This 2011 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Raise funds for breakthrough research that advances precision medicine for the prevention and treatment of women's cancers. It is the organization's hope that cancer will become a manageable disease that patients will live with and not die from, until it ceases to exist.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2011 • Form 990Summary only. Only limited summary data is available for this year.